Quick Answer
Roivant Sciences Ltd. reported Research And Development Expense of $550.41 million for the year ending 2025.
- Roivant Sciences Ltd. showed an increase of +25.1% in Research And Development Expense from 2024 to 2025.
- This data is from Roivant Sciences Ltd.'s annual report (Form 10-K), filed with the SEC on May 29, 2025.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), Roivant Sciences Ltd.'s Research And Development Expense has grown by 132.6%.
- Historical annual values: Fiscal year 2025: $550.41 million | Fiscal year 2024: $439.91 million | Fiscal year 2023: $454.06 million | Fiscal year 2022: $483.04 million | Fiscal year 2021: $236.63 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: